Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

PURPOSE: Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers. Thyroid dysfunction is the most common endocrine adverse event reported. Patients who are at risk of developing thyroid dysfunction remain to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Brilli, L., Danielli, R., Campanile, M., Secchi, C., Ciuoli, C., Calabrò, L., Pilli, T., Cartocci, A., Pacini, F., Di Giacomo, A. M., Castagna, M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285335/
https://www.ncbi.nlm.nih.gov/pubmed/33367977
http://dx.doi.org/10.1007/s40618-020-01480-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285335/
https://www.ncbi.nlm.nih.gov/pubmed/33367977
http://dx.doi.org/10.1007/s40618-020-01480-6

Ejemplares similares